21-42388941-C-T
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001256317.3(TMPRSS3):c.310G>A(p.Glu104Lys) variant causes a missense change. The variant allele was found at a frequency of 0.0000136 in 1,613,852 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E104G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001256317.3 missense
Scores
Clinical Significance
Conservation
Publications
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive nonsyndromic hearing loss 8Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TMPRSS3 | NM_001256317.3 | c.310G>A | p.Glu104Lys | missense_variant | Exon 4 of 13 | ENST00000644384.2 | NP_001243246.1 | |
| TMPRSS3 | NM_024022.4 | c.310G>A | p.Glu104Lys | missense_variant | Exon 4 of 13 | NP_076927.1 | ||
| TMPRSS3 | NM_032405.2 | c.310G>A | p.Glu104Lys | missense_variant | Exon 4 of 9 | NP_115781.1 | ||
| TMPRSS3 | NM_032404.3 | c.-72G>A | 5_prime_UTR_variant | Exon 1 of 10 | NP_115780.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| TMPRSS3 | ENST00000644384.2 | c.310G>A | p.Glu104Lys | missense_variant | Exon 4 of 13 | NM_001256317.3 | ENSP00000494414.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152232Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000795 AC: 2AN: 251460 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461620Hom.: 0 Cov.: 32 AF XY: 0.00000963 AC XY: 7AN XY: 727132 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74374 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 8 Pathogenic:2
- -
- -
not provided Pathogenic:2
- -
Reported with a second TMPRSS3 variant, phase unknown, in a patient with sensorineural non-syndromic hearing loss (PMID: 36555390); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 21534946, 36555390) -
Rare genetic deafness Pathogenic:1
The p.Glu104Lys variant in TMPRSS3 has been reported in the homozygous state in 1 Pakistani individual with hearing loss and segregated in 6 affected relatives whose parents were consanguineous (Lee 2012). This variant has been identified i n 2/66672 of European chromosomes by the Exome Aggregation Consortium (ExAC, htt p://exac.broadinstitute.org; dbSNP rs373058706); however, its frequency is low e nough to be consistent with a recessive carrier frequency. In summary, although additional studies are required to fully establish its clinical significance, t his variant is likely pathogenic for autosomal recessive nonsyndromic hearing lo ss. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at